Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Changing beta-blockers in heart failure: when is a class not a class?

× No keyword cloud information.

12 in total

Review 1. The vasodilatory beta-blockers.

Authors: Michala E Pedersen; John R Cockcroft
Journal: Curr Hypertens Rep Date: 2007-08 Impact factor: 5.369

Review 2. An overview of the pharmacodynamic properties and therapeutic potential of combined alpha- and beta-adrenoceptor antagonists.

Authors: P A van Zwieten
Journal: Drugs Date: 1993-04 Impact factor: 9.546

Review 3. Clinical relevance of pharmacokinetic differences between beta blockers.

Authors: M J Kendall
Journal: Am J Cardiol Date: 1997-11-13 Impact factor: 2.778

4. Possible significance of the pharmacological differentiation of beta-blocking agents in hemodynamic effects in essential hypertension.

Authors: H Tsukiyama; K Otsuka; M Horii; Y Yoshii; Y Hatori; Y Nakamura; E Nemoto; T Yamato; T Sakai; Y Yamamoto
Journal: Jpn Circ J Date: 1983-03

Review 5. The xamoterol experience in the treatment of heart failure.

Authors: J M Cruickshank
Journal: Am J Cardiol Date: 1993-03-25 Impact factor: 2.778

Review 6. Cardioprotection with beta-adrenoceptor blockers. Does lipophilicity matter?

Authors: A Hjalmarson
Journal: Basic Res Cardiol Date: 2000 Impact factor: 17.165

Review 7. Nebivolol: new therapy update.

Authors: Sachin S Sule; William Frishman
Journal: Cardiol Rev Date: 2006 Sep-Oct Impact factor: 2.644

8. Inhibition of endothelin-1 and KCL-induced increase of [CA2+]i by antiglaucoma drugs in cultured A7r5 vascular smooth-muscle cells.

Authors: Kwou-Yeung Wu; Hwei-Zu Wang; Show-Jen Hong
Journal: J Ocul Pharmacol Ther Date: 2004-06 Impact factor: 2.671

9. Vasodilatory mechanism of levobunolol on vascular smooth muscle cells.

Authors: Yaru Dong; Hitoshi Ishikawa; Yazhen Wu; Takeshi Yoshitomi
Journal: Exp Eye Res Date: 2007-01-27 Impact factor: 3.467

10. Identification and guided treatment of ventricular dysfunction in general practice using blood B-type natriuretic peptide.

Authors: David Mant; Fd Richard Hobbs; Paul Glasziou; Lucy Wright; Rachel Hare; Rafael Perera; Christopher Price; Martin Cowie
Journal: Br J Gen Pract Date: 2008-06 Impact factor: 5.386

3 in total

1. Public understanding of drug therapy.

Authors: Andrew Herxheimer
Journal: Br J Clin Pharmacol Date: 2012-06 Impact factor: 4.335

2. Trends and inequities in beta-blocker prescribing for heart failure.

Authors: Sunil M Shah; Iain M Carey; Stephen DeWilde; Nicky Richards; Derek G Cook
Journal: Br J Gen Pract Date: 2008-12 Impact factor: 5.386

Review 3. Me-too pharmaceutical products: History, definitions, examples, and relevance to drug shortages and essential medicines lists.

Authors: Jeffrey K Aronson; A Richard Green
Journal: Br J Clin Pharmacol Date: 2020-05-13 Impact factor: 4.335

3 in total